Medical

Scandit has signed a national contract with NHS Digital to provide data capture services as part of the UK’s response to COVID-19. As part of this, NHS organisations will have free access to Scandit’s technology to support COVID-related services such as test-tracking, PPE tracking and patient care until 30th November 2021. 

Ultrasound is widely used to detect breast cancer early, but misdiagnosis of benign lesions as malignant tumors sometimes leads to unnecessary biopsies. To tackle this problem, scientists conducted a large multi-center study involving 13 hospitals in China to train deep learning models to accurately classify breast masses. Their results, published in Chinese Medical Journal, showcase how artificial intelligence could find use as an assistive tool...

Lifesum has announced its popular mobile app now has more than 50 million registered users. Spanning 250 countries and engaging in 11 different languages, Lifesum app users receive personalised nutritional guidance based on their individual goals and lifestyle.

In-vitro diagnostics (IVD) equipment has become increasingly beneficial in helping physicians achieve faster, more accurate patient diagnoses. Join Texas Instruments for an hour-long webinar of a 40-minute presentation, followed by a 20-minute Q&A, to help address your specific design needs for building IVD systems of the future.   

Thirona has developed an AI algorithm that hopes to change cystic fibrosis (CF) care. The new algorithm, coined PRAGMA-AI, allows for fast, automated analysis of CT scans of patients with CF to detect and quantify lung abnormalities related to CF.

When the South Wales Multiple Sclerosis Therapy Centre in Swansea, a member of the national MSNTC charity, was looking to expand its oxygen therapy services to MS patients, the limitations of plant room space and reliance on infrequent oxygen delivery schedules presented major obstacles. Moving to larger premises and installing an Atlas Copco on-site oxygen generation system for 24/7 availability, has resulted in increased therapy capacity, reduc...

The Cardiac Rhythm Management (CRM) devices market is anticipated to amass considerable revenue growth on account of rising number of patients suffering from chronic cardiovascular diseases. Lately, there has been a surge in the number of sudden cardiac and arrhythmia deaths worldwide, accounting for almost 15-20% of all deaths registered globally.

With resources more constrained than ever before, healthcare providers are turning to tech to boost capacity and improve patient outcomes. Pelle Svensson, Market Development Manager, Product Center Short Range Radio, u-blox explains.

Exel Composites has launched its anti viral Protector solution, which has been proven to reduce the viral load of strains of human Coronavirus. Results have demonstrated a 99.44% reduction in viral load after one hour, and 99.99% after 24 hours, compared to untreated composites.

Recent advances and developments in the field of genomics and next-generation DNA sequencing technologies have enhanced speed and reduced the costs of DNA sequencing. The growing occurrence of chronic health conditions worldwide has encouraged the adoption of digital genome solutions.